News Headlines

Display #
Pfizer Eyes $100 Million Expansion, New Jobs in North Carolina
Former Millennium and FORUM Pharma CEO Resurfaces to Helm Massachusetts Biotech XTuit
AstraZeneca PLC Had ‘Fake Doctor’ Under Payroll in Australia
FDA Grants Orphan Drug Designation to CSRA’s DynPort Vaccine Company for Plague Vaccine
Apotex Announces $184 Million Investment to Grow U.S. Manufacturing Presence; Expansion Plan Comprises Company’s Largest Investment in the United States
Soy tied to longer life after breast cancer
Precision Medicine: What Is It And Why Now?
FDA Approves First Treatment for Nocturia
Diabetes in pregnancy tied to altered fat cells in adult offspring
Novartis' Cosentyx shows almost all psoriasis patients rapidly regain skin clearance following a treatment pause
Why Pharma Giant AstraZeneca’s Market Value Gained $3.8 Billion In February 2017
Sulforaphane, a phytochemical in broccoli sprouts, ameliorates obesity
Third Rock Ventures Quietly Launches Tango Therapeutics in Editas Medicine’s HQ
U.S. reports low pathogenic bird flu outbreak in Wisconsin: OIE
MedImmune and Sanofi Pasteur form alliance to develop and commercialise potential next-generation respiratory syncytial virus antibody MEDI8897
Trump backs House Republican healthcare plan
Boehringer Ingelheim expands collaboration with Vanderbilt University to tackle some of the most difficult-to-treat cancers
Seattle Genetics to resume trials as FDA lifts clinical hold
Phase III APHINITY study shows Roche's Perjeta® regimen helped people with an aggressive type of early breast cancer live longer without their disease returning compared to Herceptin® and chemotherapy
How molecular machines may drive the future of disease detection and drug delivery
OncoCyte says study confirms accuracy of lung cancer blood test
Vertex to Acquire CTP-656 from Concert Pharmaceuticals for the Treatment of Cystic Fibrosis
TG Therapeutics’ leukemia drug clears key study, shares soar
Current Realities of the Audience Economy, from a Programmatic Perspective
Johnson & Johnson wins trial in talc product liability lawsuits
Sanofi, Regeneron say latest Dupixent eczema drug tests positive
Oral OTEZLA (Apremilast) Demonstrated Significant Improvement versus Placebo in Trial of Patients with Moderate Plaque Psoriasis Who Were Naïve to Systemic and Biologic Therapy
Governors met on Obamacare replacement plan with Pence
Sanofi Pasteur Inks $645 Million RSV Deal With AstraZeneca’s MedImmune
The Current Realities of the Audience Economy, from a Programmatic Perspective